Malaria-infected mice cured by 1 dose of new drug

The team also has developed several other compounds which defeated the febrile disease in rodents after three oral doses.

These peroxide compounds, containing a crucial oxygen-oxygen unit, promise not only to be more effective than today's best malaria remedies, but also potentially safer and more efficient, said research team leader Gary Posner, Scowe Professor of Chemistry in the Krieger School of Arts and Sciences at Johns Hopkins.

An article about the team's work is slated to appear on the Web on April 17 in the ASAP section of The Journal of Medicinal Chemistry.

"We are disclosing, for the first time, the curative activity of a new generation of compounds that are long-lasting and therapeutic, even when used by themselves," Posner said. "Older drugs in this family of peroxide antimalarials also are known to be fast-acting, but they are unfortunately short-lived and not curative when used by themselves."

Though they say their results are very promising, the researchers caution that the new compounds must be thoroughly tested for safety and for how they are absorbed, distributed and metabolized in, and eliminated from, rodents' bodies before human tests begin.

Malaria afflicts between 300 million and 500 million people a year, killing between 1.5 million and 3 million, mostly children and mostly in developing nations. The parasite that causes the disease is spread by female mosquitoes feeding on human blood. The most commonly fatal species of the malaria parasite now shows strong resistance to most current treatments, making the development of effective new drugs a worldwide priority.

Since 1992, Posner and his team, which includes collaborator Theresa Shapiro, professor and chair of clinical pharmacology at the Johns Hopkins School of Medicine, have been tackling that challenge by designing a series of peroxide compounds, called trioxanes.

"As a class, these compounds have proven to be unusually valuable in several ways, from their brisk and potent antimalarial activity to their lack of resistance and cross-resistance with other antimalarial agents," Shapiro said.

The Johns Hopkins trioxanes mimic artemisinin, the active agent in a Chinese herbal drug used to treat malaria and other fevers for thousands of years. Artemisinin comes from the Artemisia annua plant, an herb also known by a variety of names including sweet wormwood.

The oxygen-oxygen unit in the peroxides causes malaria parasites essentially to self-destruct. The parasites digest hemoglobin, the oxygen-carrying pigment of red blood cells, and, in the process, release a substance called heme, a deep-red iron-containing blood pigment. When the heme encounters peroxides, a powerful chemical reaction occurs, releasing carbon-free radicals and oxidizing agents that eventually kill the parasites.

But the first generation of trioxane drugs also had a number of shortcomings, including a half-life of less than one hour. (A drug's half-life is the amount of time it takes for half of it to be metabolized.) Posner and team believe that their new compounds address those disadvantages.

"Our semi-synthetic artemisinin-derived compounds successfully overcome the disadvantages of their first-generation predecessors," he said. "Most important is their curative activity after a single, low dose, which is distinctly unusual. But based on our intentional design, they may also have a longer half-life in animals. We also designed them to be more lipophilic, meaning they have an enhanced ability to dissolve in fats and thus to arrive inside malaria-infected red blood cells."

In addition, the new compounds are far less likely to break down into toxic substances when they are metabolized in the test animals' bodies, making them potentially safer than their predecessors.

Although the substance is inexpensive by Western standards, the widespread use of artemisinins in the developing world remains limited, in part by availability and the cost of separating the active ingredient from the Artemisia annua plant. Posner and his team contend that the potency and curative activity of their compounds provide "a substantially more efficient and economical use of the price-setting natural product."

Source: Johns Hopkins University

Researchers team up to probe iron-arsenic superconductors with new instrument
Researchers at the U.S. Department of Energy's Ames Laboratory are part of collaborative team that's used a brand new instrument at the DOE's Spallation Neutron Source to probe iron-arsenic compounds, the "hottest" new find in the race to explain and develop superconducting materials. Rob McQueeney, an Ames Laboratory physicist, was part of that team whose findings, published in the Oct. 10 issue (101) of Physical Review Letters, mark the first research produced with the aid of the new tool.
Flexible OLEDs could be part of lighting's future
(AP) -- On a bank of the Mohawk River, a windowless industrial building of corrugated steel hides something that could make floor lamps, bedside lamps, wall sconces and nearly every other household lamp obsolete. It's a machine that prints lights.
A new explosive: Melt-castable nitrate ester with high explosive energy
Since the discovery of nitroglycerin in 1846, the nitrate ester group of compounds has been known for its explosive properties. A whole series of other nitrate esters have been subsequently put to use as explosives and fuels. A research team led by David E. Chavez at Los Alamos National Laboratory (USA) has now developed a novel tetranitrate ester. As reported in the journal Angewandte Chemie, the compound has a particularly interesting characteristic profile: it is solid at room temperature, is a highly powerful explosive, and can be melt-cast into the desired shape.
Liquid Mirror Telescopes on the Moon
A team of internationally renowned astronomers and opticians may have found a way to make "unbelievably large" telescopes on the Moon.
Deep biosphere research points to new methods for recovering petroleum
Miles below us, deep within Earth's crust, life is astir. Organisms there are not the large creatures typically envisioned when thinking of life. Instead, thriving there are microbes, the smallest and oldest form of life on Earth. Although the biological diversity of these deep biosphere microorganisms may surpass that of the more familiar surface biosphere, much about them is still unknown, including the origin of the organic compounds they consume. Arizona State University researchers are using a novel approach that integrates physical organic chemistry with organic geochemistry and biogeochemistry to uncover the source of these organic compounds.
Bad breath? Mouthrinses work, but some cause temporary staining
Over-the-counter mouthrinses really do put a stop to bad breath. The first systematic review on the effectiveness of mouthrinses shows that they play an important role in reducing levels of bacteria and chemicals that cause mouth odours. Pick which one you use though, because some can temporarily stain your tongue and teeth, warns this new review from The Cochrane Library.
Discovery of natural compounds that could slow blood vessel growth
Using computer models and live cell experiments, biomedical engineers at the Johns Hopkins University School of Medicine have discovered more than 100 human protein fragments that can slow or stop the growth of cells that make up new blood vessels.
Researchers propose minocycline as a promising drug for patients with Fragile X syndrome
A UC Riverside-led team of biomedical scientists has found that a readily available drug called minocycline, used widely to treat acne and skin infections, can be used to treat Fragile X syndrome, the most common inherited cause of mental impairment and the most common cause of autism.

Malaria-infected mice cured by 1 dose of new drug

Related stories:

News discussion: